Heba A. Ewida
Cairo, C 11835, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Mitigating loss of lean muscle in GLP-1 and dual GLP-1/GIP agonists: Pipeline opportunities and limitations.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 22, 2025
Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice.
Journal: Pharmacological research
Published: April 07, 2025
High-dose acetaminophen does not acutely compromise blood-brain barrier permeability in mice.
Journal: Metabolic brain disease
Published: November 05, 2024
Discovery of pyrazole-based analogs as CDK2 inhibitors with apoptotic-inducing activity: design, synthesis and molecular dynamics study.
Journal: RSC advances
Published: September 09, 2024
Molecular Targets and Small Molecules Modulating Acetyl Coenzyme A in Physiology and Diseases.
Journal: ACS pharmacology & translational science
Published: August 07, 2024
Reciprocal regulation of cardiac β-oxidation and pyruvate dehydrogenase by insulin.
Journal: The Journal of biological chemistry
Published: December 22, 2023
Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression.
Journal: Diagnostics (Basel, Switzerland)
Published: March 03, 2023
Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy.
Journal: Antioxidants (Basel, Switzerland)
Published: December 27, 2022
Nanomolar potency of imidazo[2,1-b]thiazole analogs as indoleamine 2,3-dioxygenase inhibitors.
Journal: Archiv der Pharmazie
Published: May 31, 2021
3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations.
Journal: Bioorganic chemistry
Published: May 02, 2021
Last Updated: 09/26/2026